Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 48, 2018 - Issue 23
286
Views
9
CrossRef citations to date
0
Altmetric
Articles

Antihyperglycemic activity of chalcone based novel 1-{3-[3-(substituted phenyl) prop-2-enoyl] phenyl} thioureas

, , , , , & show all
Pages 3015-3024 | Received 07 Aug 2018, Published online: 22 Nov 2018

References

  • American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2011, 34, S62–S69. DOI: 10.2337/dc11-S062.
  • Li, W. L.; Zheng, H. C.; Bukuru, J.; De Kimpe, N. Natural Medicines Used in Traditional Chinese Medical System for Therapy of Diabetes Mellitus. J. Ethnopharmacol. 2004, 92, 1–21. DOI: 10.1016/j.jep.2003.12.031.
  • American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2009, 32, S62–S67. DOI: 10.2337/dc09-S062.
  • King, H.; Aubert, R. E.; Herman, W. H. Global Burden of Diabetes, 1995-2025: prevalence, Numerical Estimates, and Projections. Diabetes Care. 1998, 21, 1414–1431. DOI: 10.2337/diacare.21.9.1414.
  • Tassoni, E.; Giannessi, F.; Brunetti, T.; Pessotto, P.; Renzulli, M.; Travagli, M.; Rajamäki, S.; Prati, S.; Dottori, S.; Corelli, F.; et al. Novel Substituted Aminoalkylguanidines as Potential Antihyperglycemic and Food Intake-Reducing Agents. J. Med. Chem. 2008, 51, 3073–3076. DOI: 10.1021/jm8001636.
  • Larsen, S. D.; Connell, M. A.; Cudahy, M. M.; Evans, B. R.; May, P. D.; Meglasson, M. D.; O’Sullivan, T. J.; Schostarez, H. J.; Sih, J. G.; Stevens, F. C.; et.al. Synthesis and Biological Activity of Analogues of the Antidiabetic/Antiobesity Agent 3-Guanidinopropionic: discovery of a Novel Aminoguanidinoacetic Acid Antidiabetic Agent. J. Med. Chem. 2001, 44, 1217–1230. DOI: 10.1021/jm000095f.
  • Zhang, H.; Zhang, Y. A.; Wu, G. Z.; Zhou, J. P.; Huang, W. L.; Hu, X. W. Synthesis and Biological Evaluation of Sulfonylurea and Thiourea Derivatives Substituted with Benzene Sulfonamide Groups as Potential Hypoglycemic Agents. Bioorg. Med. Chem. Lett. 2009, 19, 1740–1744. DOI: 10.1016/j.bmcl.2009.01.082.
  • Kenchappa, R.; Bodke, Y. D.; Chandrashekar, A.; Aruna Sindhe, M.; Peethambar, S. K. Synthesis of Coumarin Derivatives Containing Pyrazole and Indenone Rings as Potent Antioxidant and Antihyperglycemic Agents. Arabian J. Chem. 2017, 10, S3895–S3906. DOI: 10.1016/j.arabjc.2014.05.029.
  • Tiedge, M.; Lortz, S.; Drinkgern, J.; Lenzen, S. Relation between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing Cells. Diabetes 1997, 46, 1733–1742. DOI: 10.2337/diab.46.11.1733.
  • Rachakatla, A.; Mudigonda, S.; Kishore, G. K.; Rani, S. H. Apoptosis of Beta Cells in Diabetes Mellitus. DNA Cell Biol. 2014, 33, 743–748. DOI: 10.1089/dna.2014.2352.
  • Maedler, K.; Spinas, G. A.; Lehmann, R.; Sergeev, P.; Weber, M.; Fontana, A.; Kaiser, N.; Donath, M. Y. Glucose Induces Beta-Cell Apoptosis via Upregulation of the Fas Receptor in Human Islets. Diabetes 2001, 50, 1683–1690. DOI: 10.2337/diabetes.50.8.1683.
  • Scaglia, L.; Smith, F. E.; Bonner-Weir, S. Apoptosis Contributes to the Involution of Beta Cell Mass in the Postpartum Rat Pancreas. Endocrinology 1995, 136, 5461–5468. DOI: 10.1210/endo.136.12.7588296.
  • Acharya, J. D. Ghaskadbi, SS. Islets and Their Antioxidant Defense. Islets 2010, 2, 225–235. DOI: 10.4161/isl.2.4.12219.
  • Enoki, T.; Ohnogi, H.; Nagamine, K.; Kudo, Y.; Sugiyama, K.; Tanabe, M.; Kobayashi, E.; Sagawa, H.; Kato, I. Antidiabetic Activities of Chalcones Isolated from a Japanese Herb, Angelica Keiskei. J. Agric. Food Chem. 2007, 55, 6013–6017. DOI: 10.1021/jf070720q.
  • Rosangela, G. D.; Ana, P. Z.; Luisa, H. C.; Louise, D. C.; Alessandra, M.; Nunes, R. J.; Rosendo, A. Y.; Regina, F.; Mena, B. S. Antihyperglycemic Activity of Naphthylchalcones. Eur. J. Med. Chem. 2010, 45, 1332–1337. DOI: 10.1016/j.ejmech.2009.12.017.
  • Shukla, P.; Singh, A. B.; Srivastava, A. K.; Pratap, R. Chalcone Based Aryloxypranolamines as Potential Antihyperglycemic Agent. Bioorg. Med. Chem. 2007, 17, 799–802. DOI: 10.1016/j.bmcl.2006.10.068.
  • Satyanarayana, M.; Tiwari, P.; Tripathi, B. K.; Srivastava, A. K.; Pratap, R. Synthesis and Antihyperglycemic Activity of Chalcone Based Aryloxypropanolamines. Bioorg. Med. Chem. 2004, 12, 883–889. DOI: 10.1016/j.bmc.2003.12.026.
  • Seo, W. D.; Kim, J. H.; Kang, J. E.; Ryu, H. W.; Curtis-Long, M. J.; Lee, H. S.; Yang, M. S.; Park, K. H. Sulfonamide Chalcone as a New Class of Alpha-Glucosidase Inhibitors. Bioorg. Med. Chem. Lett. 2005, 15, 5514–5516. DOI: 10.1016/j.bmcl.2005.08.087.
  • Vaya, J.; Belinky, P. A.; Aviram, M. Antioxidant Constituents from Licorice Roots: isolation, Structure Elucidation and Antioxidative Capacity toward LDL Oxidation. Free Radic. Biol. Med. 1997, 23, 302–313. DOI: 10.1016/S0891-5849(97)00089-0.
  • Jung, S. H.; Park, S. Y.; Kim-Pak, Y.; Lee, H. K.; Park, K. S.; Shin, K. H.; Ohuchi, K.; Shin, H. K.; Keum, S. R.; Lim, S. S. Synthesis and PPAR-γ Ligand Binding Activity of the New Series of 2-Hydroxychalcone and Thiazolidinedione Derivatives. Chem. Pharm. Bull. 2006, 54, 368–371. DOI: 10.1248/cpb.54.368.
  • Jawale, D. V.; Pratap, U. R.; Rahuja, N.; Srivastava, A. K.; Mane, R. A. Synthesis and Antihyperglycemic Evaluation of New 2,4-Thiazolidinediones Having Biodynamic Aryl Sulfonylurea Moieties. Bioorg. Med. Chem. Lett. 2012, 22, 436–439. DOI: 10.1016/j.bmcl.2011.10.110.
  • Mahapatra, D. K.; Asati, V.; Bharti, S. K. Chalcones and Their Therapeutic Targets for the Management of Diabetes: structural and Pharmacological Perspectives. Eur. J. Med. Chem. 2015, 92, 839–865. DOI: 10.1016/j.ejmech.2015.01.051.
  • Cai, C. Y.; Rao, L.; Rao, Y.; Guo, J. X.; Xiao, Z. Z.; Cao, J. Y.; Huang, Z. S.; Wang, B. Analogues of Xanthones-Chalcones and Bis-Chalcones as α-Glucosidase Inhibitors and anti-Diabetes Candidates. Eur. J. Med. Chem. 2017, 130, 51–59. DOI: 10.1016/j.ejmech.2017.02.007.
  • Sun, H.; Li, Y.; Zhang, X.; Lei, Y.; Ding, W.; Zhao, X.; Wang, H.; Song, X.; Yao, Q.; Zhang, Y.; et al. Synthesis, α-Glucosidase Inhibitory and Molecular Docking Studies of Prenylated and Geranylated Flavones, Isoflavones and Chalcones. Bioorg. Med. Chem. Lett. 2015, 25, 4567–4571. DOI: 10.1016/j.bmcl.2015.08.059.
  • Chinthala, Y.; Thakur, S.; Tirunagari, S.; Chinde, S.; Domatti, A. K.; Arigari, N. K.; Srinivas, K. V. N. S.; Alam, S.; Jonnala, K. K.; Khan, F.; et al. Synthesis, Docking and ADMET Studies of Novel Chalcone Triazoles for anti-Cancer and anti-Diabetic Activity. Eur. J. Med. Chem. 2015, 93, 564–573. DOI: 10.1016/j.ejmech.2015.02.027.
  • Hsieh, C. T.; Hsieh, T. J.; El-Shazly, M.; Chuang, D. W.; Tsai, Y. H.; Yen, C. T.; Wu, S. F.; Wu, Y. C.; Chang, F. R. Synthesis of Chalcone Derivatives as Potential anti-Diabetic Agents. Bioorg. Med. Chem. Lett. 2012, 22, 3912–3915. DOI: 10.1016/j.bmcl.2012.04.108.
  • Elga, H. A.; Guollo, G. D.; Luisa, H. C.; Domeneghini, C´e. C. L.; Paulo, L.; Ricardo, J. N.; Rosendo, A.; Fatima, R. M.; Silva, B. Influence of Chalcone Analogues on Serum Glucose Levels in Hyperglycemic Rats. Chem. Biol. Interact. 2008, 171, 355–362. DOI: 10.1016/j.cbi.2007.11.001.
  • Sun, L.-P.; Gao, L.-X.; Ma, W.-P.; Nan, F.-J.; Li, J.; Piao, H.-R. Evaluation of 2,4,6- Trihydroxychalcone Derivatives as Novel Protein Tyrosin Phosphatase 1β Inhibitors. Chem. Biol. Drug Des. 2012, 80, 584–590. DOI: 10.1111/j.1747-0285.2012.01431.x.
  • Schlede, E.; Genschow, E.; Spielmann, H.; Stropp, G.; Kayser, D. Oral Acute Toxic Class Method: A Successful Alternative to the Oral LD50 Test. Regul. Toxicol. Pharmacol. 2005, 42, 15–23. DOI: 10.1016/j.yrtph.2004.12.006.
  • Olaniyan, J. M.; Muhammad, H. M.; Makun, H. A.; Busari, M. B.; Abdullah, A. S. Acute and Sub-Acute Toxicity Studies of Aqueous and Methanol Extracts of Nelsonia Campestris in Rats. J. Acute Dis. 2016, 5, 62–70. DOI: 10.1016/j.joad.2015.08.006.
  • Bandgar, B. P.; Gawande, S. S.; Bodade, R. G.; Totre, J. V.; Khobragade, C. N. Synthesis and Biological Evaluation of Simple Methoxylated Chalcones as Anticancer, anti-Inflammatory and Antioxidant Agents. Bioorg. Med. Chem. 2010, 18, 1364–1370. DOI: 10.1016/j.bmc.2009.11.066.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.